USPTO trademark

LUPELIC

RegisteredUSPTOWord markClass 5

"LUPELIC" is a word mark owned by Glaxo Group Limited, filed at the USPTO on January 13, 2025. It is registered and covers class 5 (Pharmaceuticals).

View Glaxo Group Limited portfolioGet this data via the API
Official USPTO record
LUPELIC trademark as filed
As filed with the USPTO
Status
Registered
Since June 17, 2025
Filed
January 13, 2025
Registered
June 17, 2025
Expires
Not recorded
Application no.
98956801
Registration no.
7836182
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns LUPELIC

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Glaxo Group Limited

Stevenage, United Kingdom

19,383 trademarks in the portfolioView company

Representative

Elizabeth K. Rucki

GSK

Goods and services

What the mark covers

The products and services LUPELIC is filed for, grouped by Nice class.

  • Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Assigned to examiner
  8. New application office supplied data entered
  9. New application entered
FAQ

About LUPELIC

Who owns the trademark "LUPELIC"?

The USPTO trademark "LUPELIC" (application 98956801) is owned by Glaxo Group Limited.

What is the status of "LUPELIC"?

Its status at the USPTO is: registered.

When was "LUPELIC" registered?

It was registered on June 17, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull LUPELIC and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2a53-3235-71ac-bff2-8ed709ee67fd
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a53-3235-71ac-bff2-8ed709ee67fd",
  "object": "trademark",
  "mark_text": "LUPELIC",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98956801",
  "filing_date": "2025-01-13",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Glaxo Group Limited",
      "entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
    }
  ]
}